| 0 |
BLEPHARECTOMY |
1 |
0.5000 |
| 1 |
LACRIMAL PUNCTUM ENLARGED |
1 |
0.5000 |
| 2 |
LYMPH NODE TRANSPLANT |
1 |
0.5000 |
| 3 |
GLAUCOMA DRAINAGE DEVICE EXPOSURE |
3 |
0.3750 |
| 4 |
BLEPHARITIS ALLERGIC |
9 |
0.2903 |
| 5 |
CONJUNCTIVAL LACERATION |
2 |
0.2000 |
| 6 |
CORNEA VERTICILLATA |
60 |
0.1974 |
| 7 |
CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS |
1 |
0.1250 |
| 8 |
CONJUNCTIVAL DEGENERATION |
1 |
0.1250 |
| 9 |
EYELID ABRASION |
2 |
0.1053 |
| 10 |
CORNEAL ENDOTHELIAL DISORDER |
1 |
0.0909 |
| 11 |
CONJUNCTIVAL HYPERAEMIA |
246 |
0.0689 |
| 12 |
CONJUNCTIVAL VASCULAR DISORDER |
1 |
0.0556 |
| 13 |
CHOROIDAL HAEMORRHAGE |
10 |
0.0518 |
| 14 |
CORNEAL CYST |
5 |
0.0515 |
| 15 |
CONJUNCTIVAL PIGMENTATION |
2 |
0.0500 |
| 16 |
CONJUNCTIVAL CYST |
3 |
0.0469 |
| 17 |
UVEAL PROLAPSE |
1 |
0.0455 |
| 18 |
IRIS DISCOLOURATION |
2 |
0.0435 |
| 19 |
CORNEAL OEDEMA |
95 |
0.0424 |
| 20 |
NONINFECTIVE CHORIORETINITIS |
1 |
0.0333 |
| 21 |
MACULAR DYSTROPHY CONGENITAL |
1 |
0.0323 |
| 22 |
CORNEAL BLEEDING |
3 |
0.0312 |
| 23 |
ORBITAL HAEMATOMA |
1 |
0.0294 |
| 24 |
CORNEAL DEGENERATION |
7 |
0.0289 |
| 25 |
CARDIAC SEPTAL DEFECT REPAIR |
1 |
0.0286 |
| 26 |
REFRACTION DISORDER |
8 |
0.0275 |
| 27 |
CONJUNCTIVAL FILTERING BLEB LEAK |
1 |
0.0263 |
| 28 |
HYPOTONY MACULOPATHY |
1 |
0.0244 |
| 29 |
DACRYOSTENOSIS ACQUIRED |
30 |
0.0232 |
| 30 |
FEMALE SEX HORMONE LEVEL ABNORMAL |
1 |
0.0227 |
| 31 |
OCULAR PROCEDURAL COMPLICATION |
4 |
0.0206 |
| 32 |
GIANT PAPILLARY CONJUNCTIVITIS |
1 |
0.0200 |
| 33 |
IRIS HAEMORRHAGE |
1 |
0.0196 |
| 34 |
BIRDSHOT CHORIORETINOPATHY |
1 |
0.0182 |
| 35 |
ATOPY |
5 |
0.0180 |
| 36 |
CORNEAL PIGMENTATION |
1 |
0.0175 |
| 37 |
CORNEAL NEOVASCULARISATION |
4 |
0.0162 |
| 38 |
ARCUS LIPOIDES |
1 |
0.0159 |
| 39 |
NAIL DEFORMATION |
1 |
0.0149 |
| 40 |
EYE ALLERGY |
23 |
0.0148 |
| 41 |
CONJUNCTIVAL IRRITATION |
2 |
0.0148 |
| 42 |
HYPOTONY OF EYE |
6 |
0.0143 |
| 43 |
OCULAR SURFACE DISEASE |
4 |
0.0142 |
| 44 |
ARTHROPOD INFESTATION |
1 |
0.0135 |
| 45 |
CONJUNCTIVITIS ALLERGIC |
20 |
0.0135 |
| 46 |
CONJUNCTIVAL SCAR |
2 |
0.0132 |
| 47 |
CONJUNCTIVAL DISORDER |
5 |
0.0131 |
| 48 |
PERIORBITAL DERMATITIS |
1 |
0.0128 |
| 49 |
CHOROIDAL EFFUSION |
10 |
0.0125 |
| 50 |
CORNEAL EPITHELIAL MICROCYSTS |
2 |
0.0120 |
| 51 |
EYELID BLEEDING |
2 |
0.0116 |
| 52 |
TRABECULECTOMY |
1 |
0.0109 |
| 53 |
CHOROIDAL DETACHMENT |
6 |
0.0108 |
| 54 |
CORNEAL DEPOSITS |
8 |
0.0108 |
| 55 |
CILIARY HYPERAEMIA |
1 |
0.0105 |
| 56 |
GLARE |
5 |
0.0097 |
| 57 |
INSTILLATION SITE ERYTHEMA |
5 |
0.0095 |
| 58 |
ATROPHIC GLOSSITIS |
1 |
0.0092 |
| 59 |
VOGT-KOYANAGI-HARADA DISEASE |
2 |
0.0091 |
| 60 |
KERATORHEXIS |
1 |
0.0088 |
| 61 |
PERIORBITAL INFLAMMATION |
2 |
0.0087 |
| 62 |
EYELASH THICKENING |
1 |
0.0083 |
| 63 |
CATARACT SUBCAPSULAR |
5 |
0.0082 |
| 64 |
EXPOSURE TO RADIATION |
1 |
0.0079 |
| 65 |
HYPHAEMA |
4 |
0.0077 |
| 66 |
INTRAOCULAR PRESSURE DECREASED |
4 |
0.0076 |
| 67 |
CONJUNCTIVAL HAEMORRHAGE |
29 |
0.0076 |
| 68 |
CORNEAL DEFECT |
1 |
0.0076 |
| 69 |
INSTILLATION SITE DISCOMFORT |
1 |
0.0075 |
| 70 |
INTRAOCULAR PRESSURE INCREASED |
95 |
0.0074 |
| 71 |
CORNEAL OPACITY |
10 |
0.0073 |
| 72 |
CONJUNCTIVAL ULCER |
1 |
0.0072 |
| 73 |
OCULAR STROKE |
1 |
0.0072 |
| 74 |
ADMINISTRATION SITE IRRITATION |
1 |
0.0071 |
| 75 |
OCULAR LYMPHOMA |
1 |
0.0071 |
| 76 |
NON-24-HOUR SLEEP-WAKE DISORDER |
1 |
0.0071 |
| 77 |
INSTILLATION SITE FOREIGN BODY SENSATION |
1 |
0.0069 |
| 78 |
PUNCTATE KERATITIS |
6 |
0.0065 |
| 79 |
ABSCESS SOFT TISSUE |
1 |
0.0065 |
| 80 |
INSTILLATION SITE PAIN |
16 |
0.0065 |
| 81 |
EYELID PAIN |
13 |
0.0064 |
| 82 |
OPEN GLOBE INJURY |
1 |
0.0061 |
| 83 |
CORNEAL SCAR |
3 |
0.0060 |
| 84 |
ECTROPION |
2 |
0.0059 |
| 85 |
DIABETIC RETINAL OEDEMA |
3 |
0.0059 |
| 86 |
INSTILLATION SITE SWELLING |
1 |
0.0057 |
| 87 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
4 |
0.0057 |
| 88 |
EYELASH CHANGES |
1 |
0.0056 |
| 89 |
EYE INFECTION FUNGAL |
2 |
0.0052 |
| 90 |
CORNEAL TRANSPLANT |
4 |
0.0051 |
| 91 |
INTRAOCULAR PRESSURE FLUCTUATION |
1 |
0.0051 |
| 92 |
REACTION TO PRESERVATIVES |
4 |
0.0049 |
| 93 |
BLEPHARITIS |
19 |
0.0047 |
| 94 |
CHOLELITHOTOMY |
1 |
0.0046 |
| 95 |
SUPERFICIAL INJURY OF EYE |
5 |
0.0046 |
| 96 |
RIGHT-TO-LEFT CARDIAC SHUNT |
1 |
0.0045 |
| 97 |
MEIBOMIAN GLAND DYSFUNCTION |
2 |
0.0044 |
| 98 |
CYSTOID MACULAR OEDEMA |
8 |
0.0042 |
| 99 |
ABSENCE OF IMMEDIATE TREATMENT RESPONSE |
1 |
0.0042 |
| 100 |
VITREOUS DISORDER |
2 |
0.0041 |
| 101 |
TYPE V HYPERLIPIDAEMIA |
2 |
0.0041 |
| 102 |
INCISION SITE DISCHARGE |
1 |
0.0040 |
| 103 |
CORNEAL THINNING |
1 |
0.0039 |
| 104 |
BACTERIAL ENDOPHTHALMITIS |
1 |
0.0038 |
| 105 |
FOREIGN BODY SENSATION IN EYES |
23 |
0.0036 |
| 106 |
OCULAR HYPERTENSION |
7 |
0.0036 |
| 107 |
PRODUCT CLOSURE ISSUE |
2 |
0.0036 |
| 108 |
SUDDEN VISUAL LOSS |
1 |
0.0036 |
| 109 |
RETINAL OPERATION |
1 |
0.0036 |
| 110 |
EYELID IRRITATION |
9 |
0.0036 |
| 111 |
PERIORBITAL PAIN |
3 |
0.0035 |
| 112 |
AGONAL RESPIRATION |
1 |
0.0035 |
| 113 |
ANDROGENETIC ALOPECIA |
1 |
0.0035 |
| 114 |
EYELID THICKENING |
1 |
0.0035 |
| 115 |
ERYTHEMA OF EYELID |
19 |
0.0035 |
| 116 |
CORNEAL EPITHELIUM DEFECT |
2 |
0.0034 |
| 117 |
OCULAR HYPERAEMIA |
162 |
0.0034 |
| 118 |
PRODUCT DELIVERY MECHANISM ISSUE |
18 |
0.0033 |
| 119 |
VISUAL ACUITY REDUCED TRANSIENTLY |
1 |
0.0032 |
| 120 |
INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS |
1 |
0.0032 |
| 121 |
CORNEAL DISORDER |
7 |
0.0032 |
| 122 |
EYELID MARGIN CRUSTING |
9 |
0.0031 |
| 123 |
LACRIMATION INCREASED |
94 |
0.0031 |
| 124 |
CATARACT NUCLEAR |
2 |
0.0030 |
| 125 |
IRITIS |
9 |
0.0030 |
| 126 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
3 |
0.0029 |
| 127 |
VIRAL DIARRHOEA |
1 |
0.0029 |
| 128 |
TACHYPHYLAXIS |
1 |
0.0029 |
| 129 |
PATIENT ELOPEMENT |
1 |
0.0027 |
| 130 |
OBSESSIVE-COMPULSIVE SYMPTOM |
1 |
0.0027 |
| 131 |
VISUAL ACUITY REDUCED |
89 |
0.0027 |
| 132 |
NEUROSARCOIDOSIS |
1 |
0.0027 |
| 133 |
HALO VISION |
3 |
0.0027 |
| 134 |
INSTILLATION SITE PRURITUS |
1 |
0.0027 |
| 135 |
EYE PAIN |
149 |
0.0026 |
| 136 |
CAUDA EQUINA SYNDROME |
2 |
0.0026 |
| 137 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
1 |
0.0026 |
| 138 |
EYELIDS PRURITUS |
8 |
0.0026 |
| 139 |
EYELID EXFOLIATION |
2 |
0.0025 |
| 140 |
PHYSICAL PRODUCT LABEL ISSUE |
3 |
0.0025 |
| 141 |
BLOOD URIC ACID ABNORMAL |
1 |
0.0025 |
| 142 |
HYPOPYON |
2 |
0.0024 |
| 143 |
DYSCHROMATOPSIA |
2 |
0.0024 |
| 144 |
RETINAL PIGMENT EPITHELIOPATHY |
1 |
0.0023 |
| 145 |
ENDOCRINE OPHTHALMOPATHY |
2 |
0.0023 |
| 146 |
HERPES OPHTHALMIC |
3 |
0.0023 |
| 147 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
1 |
0.0022 |
| 148 |
CORNEAL ABRASION |
3 |
0.0022 |
| 149 |
BODY MASS INDEX DECREASED |
1 |
0.0022 |
| 150 |
EYE IRRITATION |
123 |
0.0021 |
| 151 |
BLOOD PHOSPHORUS ABNORMAL |
1 |
0.0021 |
| 152 |
MEAN CELL VOLUME ABNORMAL |
1 |
0.0021 |
| 153 |
KERATIC PRECIPITATES |
1 |
0.0021 |
| 154 |
MYOPIA |
5 |
0.0021 |
| 155 |
EYE PRURITUS |
70 |
0.0021 |
| 156 |
BLOOD BICARBONATE INCREASED |
1 |
0.0021 |
| 157 |
PATIENT DISSATISFACTION WITH TREATMENT |
4 |
0.0021 |
| 158 |
SWELLING OF EYELID |
13 |
0.0021 |
| 159 |
EYELID RASH |
2 |
0.0020 |
| 160 |
EYE DISCHARGE |
21 |
0.0020 |
| 161 |
BLEPHARAL PIGMENTATION |
1 |
0.0020 |
| 162 |
KERATITIS |
6 |
0.0020 |
| 163 |
CONJUNCTIVAL OEDEMA |
2 |
0.0019 |
| 164 |
RETINAL VASCULAR THROMBOSIS |
1 |
0.0019 |
| 165 |
KERATOPATHY |
3 |
0.0019 |
| 166 |
OCULAR DISCOMFORT |
21 |
0.0019 |
| 167 |
CORNEAL EROSION |
1 |
0.0019 |
| 168 |
DENTAL IMPLANTATION |
3 |
0.0018 |
| 169 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 170 |
OPHTHALMIC HERPES SIMPLEX |
1 |
0.0017 |
| 171 |
PRODUCT CONTAINER SEAL ISSUE |
3 |
0.0017 |
| 172 |
SUTURE INSERTION |
1 |
0.0017 |
| 173 |
HYPOAESTHESIA EYE |
1 |
0.0017 |
| 174 |
INSTILLATION SITE IRRITATION |
2 |
0.0017 |
| 175 |
EYELID SKIN DRYNESS |
2 |
0.0016 |
| 176 |
CORTISOL INCREASED |
1 |
0.0016 |
| 177 |
CHALAZION |
1 |
0.0016 |
| 178 |
NEUROPATHIC ARTHROPATHY |
1 |
0.0015 |
| 179 |
RETINAL DISORDER |
4 |
0.0015 |
| 180 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
4 |
0.0015 |
| 181 |
HALLUCINATION, TACTILE |
1 |
0.0015 |
| 182 |
POST PROCEDURAL SEPSIS |
1 |
0.0015 |
| 183 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 184 |
PHOTOPHOBIA |
28 |
0.0015 |
| 185 |
UVEITIS |
20 |
0.0015 |
| 186 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 187 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 188 |
PRODUCT CONTAINER ISSUE |
12 |
0.0014 |
| 189 |
EYE INFLAMMATION |
13 |
0.0014 |
| 190 |
RETINAL VASCULAR OCCLUSION |
1 |
0.0013 |
| 191 |
PRODUCT PACKAGE ASSOCIATED INJURY |
3 |
0.0013 |
| 192 |
BASOPHIL COUNT INCREASED |
1 |
0.0013 |
| 193 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
1 |
0.0013 |
| 194 |
PRODUCT DEPOSIT |
2 |
0.0013 |
| 195 |
PRODUCT DROPPER ISSUE |
1 |
0.0013 |
| 196 |
DEVICE DAMAGE |
1 |
0.0013 |
| 197 |
FEAR OF FALLING |
1 |
0.0012 |
| 198 |
EYE OEDEMA |
3 |
0.0012 |
| 199 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 200 |
VISION BLURRED |
165 |
0.0012 |
| 201 |
SEROUS RETINAL DETACHMENT |
1 |
0.0012 |
| 202 |
RETINAL ARTERY OCCLUSION |
3 |
0.0012 |
| 203 |
BLOOD CHLORIDE DECREASED |
3 |
0.0012 |
| 204 |
TREATMENT DELAYED |
2 |
0.0012 |
| 205 |
GASTROINTESTINAL NEOPLASM |
1 |
0.0012 |
| 206 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 207 |
ESSENTIAL HYPERTENSION |
2 |
0.0011 |
| 208 |
BONE CONTUSION |
1 |
0.0011 |
| 209 |
GLAUCOMA |
21 |
0.0011 |
| 210 |
PRODUCT SHAPE ISSUE |
1 |
0.0011 |
| 211 |
RETINAL OEDEMA |
2 |
0.0010 |
| 212 |
FOREIGN BODY IN EYE |
1 |
0.0010 |
| 213 |
RED BLOOD CELL ABNORMALITY |
1 |
0.0010 |
| 214 |
HYPERAEMIA |
2 |
0.0010 |
| 215 |
CARDIAC ANEURYSM |
1 |
0.0010 |
| 216 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 217 |
BUTTERFLY RASH |
1 |
0.0010 |
| 218 |
EYE COLOUR CHANGE |
1 |
0.0010 |
| 219 |
IRIDOCYCLITIS |
3 |
0.0009 |
| 220 |
ALLERGY TO ANIMAL |
1 |
0.0009 |
| 221 |
NEUROMYOPATHY |
1 |
0.0009 |
| 222 |
ABNORMAL SENSATION IN EYE |
4 |
0.0009 |
| 223 |
EXOPHTHALMOS |
2 |
0.0009 |
| 224 |
HORDEOLUM |
4 |
0.0009 |
| 225 |
UTERINE PROLAPSE |
1 |
0.0009 |
| 226 |
KIDNEY ENLARGEMENT |
1 |
0.0009 |
| 227 |
INSTILLATION SITE REACTION |
1 |
0.0009 |
| 228 |
GASTROINTESTINAL TRACT IRRITATION |
1 |
0.0009 |
| 229 |
DEMENTIA WITH LEWY BODIES |
1 |
0.0009 |
| 230 |
PERIORBITAL SWELLING |
5 |
0.0009 |
| 231 |
BLOOD LOSS ANAEMIA |
2 |
0.0009 |
| 232 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 233 |
SURGICAL FAILURE |
1 |
0.0009 |
| 234 |
MACROCYTOSIS |
1 |
0.0009 |
| 235 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 236 |
DRY EYE |
43 |
0.0009 |
| 237 |
INCISION SITE PAIN |
1 |
0.0009 |
| 238 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 239 |
RECTAL PROLAPSE |
1 |
0.0008 |
| 240 |
EYE HAEMORRHAGE |
11 |
0.0008 |
| 241 |
HAEMATOCRIT ABNORMAL |
1 |
0.0008 |
| 242 |
CONJUNCTIVITIS |
15 |
0.0008 |
| 243 |
MALIGNANT MELANOMA IN SITU |
1 |
0.0008 |
| 244 |
HYPERAESTHESIA TEETH |
1 |
0.0008 |
| 245 |
SEROMA |
1 |
0.0008 |
| 246 |
CAROTID ARTERY DISEASE |
1 |
0.0008 |
| 247 |
EYELID OEDEMA |
9 |
0.0008 |
| 248 |
BILIARY OBSTRUCTION |
1 |
0.0008 |
| 249 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 250 |
ACROCHORDON |
1 |
0.0008 |
| 251 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
0.0008 |
| 252 |
CYSTITIS NONINFECTIVE |
1 |
0.0007 |
| 253 |
PRODUCT SIZE ISSUE |
4 |
0.0007 |
| 254 |
POSTPARTUM HAEMORRHAGE |
1 |
0.0007 |
| 255 |
CALCULUS BLADDER |
1 |
0.0007 |
| 256 |
INTESTINAL MASS |
1 |
0.0007 |
| 257 |
ULCERATIVE KERATITIS |
2 |
0.0007 |
| 258 |
ASTHENOPIA |
4 |
0.0007 |
| 259 |
EYE SWELLING |
27 |
0.0007 |
| 260 |
VITREOUS HAEMORRHAGE |
2 |
0.0007 |
| 261 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 262 |
BLINDNESS UNILATERAL |
10 |
0.0007 |
| 263 |
PHARYNGEAL DISORDER |
2 |
0.0007 |
| 264 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 265 |
EYELID PTOSIS |
7 |
0.0007 |
| 266 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 267 |
DARK CIRCLES UNDER EYES |
1 |
0.0007 |
| 268 |
APRAXIA |
1 |
0.0007 |
| 269 |
SQUAMOUS CELL CARCINOMA OF SKIN |
4 |
0.0007 |
| 270 |
ASTIGMATISM |
1 |
0.0007 |
| 271 |
EYE OPERATION |
3 |
0.0007 |
| 272 |
SCLERITIS |
1 |
0.0006 |
| 273 |
EYE INFECTION |
7 |
0.0006 |
| 274 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 275 |
OXYGEN THERAPY |
1 |
0.0006 |
| 276 |
BLOOD CALCIUM ABNORMAL |
1 |
0.0006 |
| 277 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 278 |
PRODUCT LABEL ISSUE |
4 |
0.0006 |
| 279 |
MEDICAL DEVICE REMOVAL |
1 |
0.0006 |
| 280 |
SENSITIVITY OF TEETH |
1 |
0.0006 |
| 281 |
GENERALISED OEDEMA |
7 |
0.0006 |
| 282 |
MITRAL VALVE DISEASE |
1 |
0.0006 |
| 283 |
FEAR OF DISEASE |
1 |
0.0006 |
| 284 |
TRANSPLANT DYSFUNCTION |
1 |
0.0006 |
| 285 |
CARDIAC ABLATION |
1 |
0.0006 |
| 286 |
OPHTHALMIC HERPES ZOSTER |
1 |
0.0006 |
| 287 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 288 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 289 |
METAMORPHOPSIA |
1 |
0.0005 |
| 290 |
BLINDNESS TRANSIENT |
4 |
0.0005 |
| 291 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 292 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 293 |
GINGIVAL RECESSION |
1 |
0.0005 |
| 294 |
CYTOMEGALOVIRUS CHORIORETINITIS |
1 |
0.0005 |
| 295 |
HYPOGEUSIA |
1 |
0.0005 |
| 296 |
COLOSTOMY |
1 |
0.0005 |
| 297 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 298 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 299 |
PRODUCT ADMINISTRATION ERROR |
10 |
0.0005 |
| 300 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 301 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
| 302 |
EAR SWELLING |
1 |
0.0005 |
| 303 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 304 |
RETROPERITONEAL HAEMATOMA |
1 |
0.0005 |
| 305 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 306 |
FACIAL PAIN |
4 |
0.0004 |
| 307 |
BRAIN OPERATION |
1 |
0.0004 |
| 308 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 309 |
MENOPAUSAL SYMPTOMS |
1 |
0.0004 |
| 310 |
SINUS PAIN |
1 |
0.0004 |
| 311 |
ORAL SURGERY |
1 |
0.0004 |
| 312 |
MACULAR DEGENERATION |
5 |
0.0004 |
| 313 |
VISUAL IMPAIRMENT |
51 |
0.0004 |
| 314 |
DERMAL CYST |
1 |
0.0004 |
| 315 |
VITREOUS FLOATERS |
4 |
0.0004 |
| 316 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 317 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 318 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 319 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 320 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 321 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 322 |
PRODUCT RESIDUE PRESENT |
2 |
0.0004 |
| 323 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 324 |
SKIN WRINKLING |
1 |
0.0004 |
| 325 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
2 |
0.0004 |
| 326 |
TRICHORRHEXIS |
1 |
0.0004 |
| 327 |
MACULAR OEDEMA |
2 |
0.0004 |
| 328 |
IMPAIRED DRIVING ABILITY |
4 |
0.0004 |
| 329 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 330 |
RETINAL VEIN OCCLUSION |
1 |
0.0003 |
| 331 |
BLOOD MAGNESIUM DECREASED |
3 |
0.0003 |
| 332 |
IMMUNOSUPPRESSION |
3 |
0.0003 |
| 333 |
THORACIC VERTEBRAL FRACTURE |
1 |
0.0003 |
| 334 |
PRODUCT DOSE OMISSION ISSUE |
98 |
0.0003 |
| 335 |
PRODUCT DISTRIBUTION ISSUE |
3 |
0.0003 |
| 336 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 337 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 338 |
BLEPHAROSPASM |
2 |
0.0003 |
| 339 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 340 |
PRODUCT PACKAGING ISSUE |
3 |
0.0003 |
| 341 |
SNEEZING |
7 |
0.0003 |
| 342 |
HAEMOGLOBIN ABNORMAL |
2 |
0.0003 |
| 343 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 344 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 345 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 346 |
PROSTATE CANCER METASTATIC |
1 |
0.0003 |
| 347 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 348 |
DIABETIC RETINOPATHY |
1 |
0.0003 |
| 349 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
1 |
0.0003 |
| 350 |
EUPHORIC MOOD |
3 |
0.0003 |
| 351 |
REGURGITATION |
1 |
0.0003 |
| 352 |
RESPIRATION ABNORMAL |
2 |
0.0003 |
| 353 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 354 |
EAR PRURITUS |
1 |
0.0003 |
| 355 |
MACULOPATHY |
1 |
0.0003 |
| 356 |
BODY HEIGHT DECREASED |
3 |
0.0003 |
| 357 |
ACCIDENTAL OVERDOSE |
10 |
0.0003 |
| 358 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 359 |
SENSITIVE SKIN |
2 |
0.0003 |
| 360 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 361 |
THROAT CLEARING |
1 |
0.0003 |
| 362 |
REBOUND EFFECT |
3 |
0.0003 |
| 363 |
FACE INJURY |
1 |
0.0003 |
| 364 |
INSURANCE ISSUE |
4 |
0.0003 |
| 365 |
LOW DENSITY LIPOPROTEIN INCREASED |
2 |
0.0003 |
| 366 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 367 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 368 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 369 |
SPINAL FUSION SURGERY |
1 |
0.0002 |
| 370 |
RECURRENT CANCER |
1 |
0.0002 |
| 371 |
SMALL INTESTINAL OBSTRUCTION |
3 |
0.0002 |
| 372 |
SELF-MEDICATION |
1 |
0.0002 |
| 373 |
EYE DISORDER |
8 |
0.0002 |
| 374 |
PRODUCT STORAGE ERROR |
21 |
0.0002 |
| 375 |
ONYCHOMADESIS |
1 |
0.0002 |
| 376 |
SLEEP TERROR |
1 |
0.0002 |
| 377 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 378 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 379 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 380 |
EXPOSURE VIA SKIN CONTACT |
6 |
0.0002 |
| 381 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 382 |
IMMOBILE |
1 |
0.0002 |
| 383 |
BEDRIDDEN |
3 |
0.0002 |
| 384 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 385 |
DRUG EFFECT DELAYED |
1 |
0.0002 |
| 386 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 387 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 388 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 389 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 390 |
NEPHROPATHY |
2 |
0.0002 |
| 391 |
UMBILICAL HERNIA |
1 |
0.0002 |
| 392 |
ARTERIOSCLEROSIS |
2 |
0.0002 |
| 393 |
SKIN ABRASION |
1 |
0.0002 |
| 394 |
THERAPY INTERRUPTED |
15 |
0.0002 |
| 395 |
LIMB OPERATION |
1 |
0.0002 |
| 396 |
PRESCRIBED OVERDOSE |
4 |
0.0002 |
| 397 |
VITAMIN D DEFICIENCY |
2 |
0.0002 |
| 398 |
HOSPICE CARE |
2 |
0.0002 |
| 399 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 400 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 401 |
INABILITY TO AFFORD MEDICATION |
2 |
0.0002 |
| 402 |
SLUGGISHNESS |
2 |
0.0002 |
| 403 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 404 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 405 |
VARICOSE VEIN |
1 |
0.0002 |
| 406 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 407 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 408 |
DIPLOPIA |
5 |
0.0002 |
| 409 |
ACUTE MYELOID LEUKAEMIA |
3 |
0.0002 |
| 410 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 411 |
DISEASE RECURRENCE |
9 |
0.0002 |
| 412 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 413 |
CHEILITIS |
1 |
0.0002 |
| 414 |
HIP SURGERY |
1 |
0.0002 |
| 415 |
SKIN LACERATION |
2 |
0.0002 |
| 416 |
HYDROCEPHALUS |
1 |
0.0002 |
| 417 |
CHOKING SENSATION |
1 |
0.0002 |
| 418 |
PROSTATIC DISORDER |
1 |
0.0002 |
| 419 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 420 |
OFF LABEL USE |
158 |
0.0002 |
| 421 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 422 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 423 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 424 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 425 |
MADAROSIS |
2 |
0.0002 |
| 426 |
METABOLIC DISORDER |
1 |
0.0002 |
| 427 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 428 |
DEVICE USE ISSUE |
3 |
0.0002 |
| 429 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 430 |
ENERGY INCREASED |
1 |
0.0002 |
| 431 |
CATARACT OPERATION |
1 |
0.0002 |
| 432 |
SINUS HEADACHE |
1 |
0.0002 |
| 433 |
ODYNOPHAGIA |
1 |
0.0002 |
| 434 |
ENDOPHTHALMITIS |
1 |
0.0002 |
| 435 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 436 |
NOCTURIA |
2 |
0.0002 |
| 437 |
INGUINAL HERNIA |
1 |
0.0002 |
| 438 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 439 |
SPINAL OPERATION |
2 |
0.0002 |
| 440 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 441 |
PHOTOPSIA |
1 |
0.0002 |
| 442 |
GASTRIC ULCER |
3 |
0.0002 |
| 443 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 444 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 445 |
EAR PAIN |
3 |
0.0002 |
| 446 |
RESPIRATORY TRACT INFECTION |
4 |
0.0002 |
| 447 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
31 |
0.0002 |
| 448 |
SOMNAMBULISM |
1 |
0.0002 |
| 449 |
CATARACT |
9 |
0.0002 |
| 450 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 451 |
PRESCRIBED UNDERDOSE |
3 |
0.0002 |
| 452 |
SKIN MASS |
1 |
0.0001 |
| 453 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 454 |
BLINDNESS |
6 |
0.0001 |
| 455 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 456 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 457 |
DROOLING |
1 |
0.0001 |
| 458 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 459 |
HAND FRACTURE |
1 |
0.0001 |
| 460 |
THERMAL BURN |
1 |
0.0001 |
| 461 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 462 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 463 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
3 |
0.0001 |
| 464 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 465 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 466 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 467 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 468 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 469 |
HYPERSENSITIVITY |
25 |
0.0001 |
| 470 |
FEELING DRUNK |
1 |
0.0001 |
| 471 |
DRUG INTOLERANCE |
13 |
0.0001 |
| 472 |
PAROSMIA |
1 |
0.0001 |
| 473 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 474 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 475 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 476 |
CONCUSSION |
1 |
0.0001 |
| 477 |
OEDEMA |
7 |
0.0001 |
| 478 |
APHTHOUS ULCER |
1 |
0.0001 |
| 479 |
BRAIN FOG |
2 |
0.0001 |
| 480 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 481 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 482 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 483 |
UTERINE CANCER |
1 |
0.0001 |
| 484 |
BLOOD PRESSURE INCREASED |
19 |
0.0001 |
| 485 |
SENSORY LOSS |
1 |
0.0001 |
| 486 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 487 |
SWELLING FACE |
8 |
0.0001 |
| 488 |
ABNORMAL FAECES |
1 |
0.0001 |
| 489 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 490 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 491 |
LIVE BIRTH |
1 |
0.0001 |
| 492 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 493 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 494 |
PRODUCT COMPLAINT |
3 |
0.0001 |
| 495 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 496 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 497 |
DEVICE DEFECTIVE |
2 |
0.0001 |
| 498 |
GASTRITIS |
3 |
0.0001 |
| 499 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 500 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 501 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 502 |
GASTROINTESTINAL CARCINOMA |
1 |
0.0001 |
| 503 |
LIP DRY |
1 |
0.0001 |
| 504 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0001 |
| 505 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 506 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 507 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 508 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 509 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 510 |
PAIN IN JAW |
3 |
0.0001 |
| 511 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 512 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 513 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 514 |
LETHARGY |
6 |
0.0001 |
| 515 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 516 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 517 |
ATELECTASIS |
1 |
0.0001 |
| 518 |
HERNIA |
2 |
0.0001 |
| 519 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 520 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 521 |
KIDNEY INFECTION |
2 |
0.0001 |
| 522 |
THERAPY CHANGE |
1 |
0.0001 |
| 523 |
SINUS DISORDER |
2 |
0.0001 |
| 524 |
EMPHYSEMA |
1 |
0.0001 |
| 525 |
EXTRA DOSE ADMINISTERED |
4 |
0.0001 |
| 526 |
DISCOMFORT |
6 |
0.0001 |
| 527 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 528 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 529 |
EAR DISCOMFORT |
1 |
0.0001 |
| 530 |
THERAPY CESSATION |
5 |
0.0001 |
| 531 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 532 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 533 |
COVID-19 |
17 |
0.0001 |
| 534 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 535 |
TENDERNESS |
1 |
0.0001 |
| 536 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 537 |
DERMATITIS |
2 |
0.0001 |
| 538 |
TRANSFUSION |
1 |
0.0001 |
| 539 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 540 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 541 |
SKIN CANCER |
2 |
0.0001 |
| 542 |
HALLUCINATION |
7 |
0.0001 |
| 543 |
BACK INJURY |
1 |
0.0001 |
| 544 |
INTENTIONAL PRODUCT MISUSE |
8 |
0.0001 |
| 545 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 546 |
HEADACHE |
57 |
0.0001 |
| 547 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 548 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 549 |
FOOT DEFORMITY |
1 |
0.0001 |
| 550 |
NERVE INJURY |
1 |
0.0001 |
| 551 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 552 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 553 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 554 |
FLATULENCE |
5 |
0.0001 |
| 555 |
SCAB |
1 |
0.0001 |
| 556 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 557 |
TINNITUS |
4 |
0.0001 |
| 558 |
DRY MOUTH |
7 |
0.0001 |
| 559 |
VASCULITIS |
1 |
0.0001 |
| 560 |
BLOOD CHOLESTEROL INCREASED |
4 |
0.0001 |
| 561 |
DYSPHONIA |
5 |
0.0001 |
| 562 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 563 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 564 |
CYTOPENIA |
1 |
0.0001 |
| 565 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 566 |
HAEMATEMESIS |
2 |
0.0001 |
| 567 |
FLUID RETENTION |
4 |
0.0001 |
| 568 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 569 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 570 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 571 |
MYDRIASIS |
1 |
0.0001 |
| 572 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 573 |
ACCIDENTAL EXPOSURE TO PRODUCT |
8 |
0.0001 |
| 574 |
SKIN ULCER |
2 |
0.0001 |
| 575 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 576 |
PARAESTHESIA |
12 |
0.0001 |
| 577 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 578 |
TOOTH INFECTION |
1 |
0.0001 |
| 579 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 580 |
ADVERSE REACTION |
1 |
0.0001 |
| 581 |
CARDIAC FAILURE CONGESTIVE |
6 |
0.0001 |
| 582 |
SINUS CONGESTION |
1 |
0.0001 |
| 583 |
DYSKINESIA |
3 |
0.0001 |
| 584 |
LIMB INJURY |
2 |
0.0001 |
| 585 |
TACHYPNOEA |
1 |
0.0001 |
| 586 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 587 |
TREATMENT NONCOMPLIANCE |
4 |
0.0001 |
| 588 |
DEVICE DELIVERY SYSTEM ISSUE |
2 |
0.0001 |
| 589 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 590 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 591 |
HUNGER |
1 |
0.0001 |
| 592 |
DEMENTIA |
2 |
0.0001 |
| 593 |
BLISTER |
4 |
0.0001 |
| 594 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 595 |
SLEEP DISORDER |
5 |
0.0001 |
| 596 |
HEART RATE INCREASED |
7 |
0.0001 |
| 597 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 598 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
5 |
0.0001 |
| 599 |
BRONCHOSPASM |
1 |
0.0001 |
| 600 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 601 |
HYPERSOMNIA |
2 |
0.0001 |
| 602 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 603 |
ANOSMIA |
1 |
0.0001 |
| 604 |
HYPOKINESIA |
1 |
0.0001 |
| 605 |
APATHY |
1 |
0.0001 |
| 606 |
PALPITATIONS |
8 |
0.0001 |
| 607 |
NASAL CONGESTION |
4 |
0.0001 |
| 608 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 609 |
DISEASE PROGRESSION |
8 |
0.0001 |
| 610 |
INSOMNIA |
18 |
0.0001 |
| 611 |
BRONCHITIS |
5 |
0.0001 |
| 612 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 613 |
THROAT IRRITATION |
3 |
0.0001 |
| 614 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 615 |
ABDOMINAL DISCOMFORT |
11 |
0.0001 |
| 616 |
NASOPHARYNGITIS |
12 |
0.0001 |
| 617 |
DEATH |
56 |
0.0001 |
| 618 |
THYROID DISORDER |
1 |
0.0001 |
| 619 |
LYMPHOMA |
1 |
0.0001 |
| 620 |
ANKLE FRACTURE |
1 |
0.0001 |
| 621 |
URINARY TRACT INFECTION |
11 |
0.0001 |
| 622 |
DELUSION |
1 |
0.0001 |
| 623 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 624 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 625 |
ULCER |
1 |
0.0001 |
| 626 |
MIGRAINE |
6 |
0.0001 |
| 627 |
ABSCESS |
1 |
0.0001 |
| 628 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 629 |
BLOOD GLUCOSE DECREASED |
3 |
0.0001 |
| 630 |
DIZZINESS |
31 |
0.0001 |
| 631 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 632 |
IMPAIRED HEALING |
2 |
0.0001 |
| 633 |
FATIGUE |
47 |
0.0001 |
| 634 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
0.0001 |
| 635 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 636 |
DRUG INEFFECTIVE |
79 |
0.0001 |
| 637 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 638 |
CELLULITIS |
3 |
0.0001 |
| 639 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 640 |
SINUSITIS |
6 |
0.0001 |
| 641 |
HAEMOGLOBIN DECREASED |
6 |
0.0001 |
| 642 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 643 |
INFLAMMATION |
3 |
0.0001 |
| 644 |
PARANOIA |
1 |
0.0001 |
| 645 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 646 |
OEDEMA PERIPHERAL |
7 |
0.0001 |
| 647 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 648 |
SYRINGE ISSUE |
1 |
0.0001 |
| 649 |
HEART RATE DECREASED |
2 |
0.0001 |
| 650 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 651 |
HYPOXIA |
2 |
0.0001 |
| 652 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 653 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 654 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 655 |
THIRST |
1 |
0.0001 |
| 656 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
10 |
0.0001 |
| 657 |
BONE DISORDER |
1 |
0.0001 |
| 658 |
PANIC ATTACK |
2 |
0.0001 |
| 659 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 660 |
FEELING ABNORMAL |
13 |
0.0001 |
| 661 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 662 |
CHEST PAIN |
10 |
0.0001 |
| 663 |
DYSGEUSIA |
4 |
0.0001 |
| 664 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 665 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 666 |
ERYTHEMA |
11 |
0.0001 |
| 667 |
COUGH |
15 |
0.0001 |
| 668 |
EPISTAXIS |
4 |
0.0001 |
| 669 |
CARDIAC DISORDER |
5 |
0.0001 |
| 670 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 671 |
HOT FLUSH |
4 |
0.0001 |
| 672 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 673 |
FEELING JITTERY |
1 |
0.0001 |
| 674 |
INCREASED APPETITE |
1 |
0.0001 |
| 675 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 676 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 677 |
DECREASED APPETITE |
12 |
0.0001 |
| 678 |
PRODUCT QUALITY ISSUE |
7 |
0.0001 |
| 679 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 680 |
ORAL HERPES |
1 |
0.0001 |
| 681 |
BONE PAIN |
3 |
0.0001 |
| 682 |
SURGERY |
3 |
0.0001 |
| 683 |
MEMORY IMPAIRMENT |
7 |
0.0001 |
| 684 |
ALOPECIA |
10 |
0.0001 |
| 685 |
DYSPEPSIA |
5 |
0.0001 |
| 686 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 687 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 688 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 689 |
SPINAL FRACTURE |
1 |
0.0000 |
| 690 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 691 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 692 |
CONDITION AGGRAVATED |
15 |
0.0000 |
| 693 |
TASTE DISORDER |
1 |
0.0000 |
| 694 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 695 |
VERTIGO |
3 |
0.0000 |
| 696 |
RIB FRACTURE |
1 |
0.0000 |
| 697 |
PRODUCT USE IN UNAPPROVED INDICATION |
12 |
0.0000 |
| 698 |
DEPRESSION |
11 |
0.0000 |
| 699 |
RASH |
21 |
0.0000 |
| 700 |
FALL |
16 |
0.0000 |
| 701 |
MOUTH ULCERATION |
1 |
0.0000 |
| 702 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 703 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 704 |
HYPERTENSION |
10 |
0.0000 |
| 705 |
RETCHING |
1 |
0.0000 |
| 706 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 707 |
NAUSEA |
37 |
0.0000 |
| 708 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 709 |
HYPOACUSIS |
2 |
0.0000 |
| 710 |
RHINORRHOEA |
3 |
0.0000 |
| 711 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 712 |
WHITE BLOOD CELL COUNT DECREASED |
5 |
0.0000 |
| 713 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 714 |
TACHYCARDIA |
4 |
0.0000 |
| 715 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 716 |
INFLUENZA |
5 |
0.0000 |
| 717 |
SOMNOLENCE |
9 |
0.0000 |
| 718 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 719 |
CHROMATURIA |
1 |
0.0000 |
| 720 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 721 |
PRURITUS |
17 |
0.0000 |
| 722 |
NO ADVERSE EVENT |
8 |
0.0000 |
| 723 |
INCORRECT DOSE ADMINISTERED |
10 |
0.0000 |
| 724 |
SKIN IRRITATION |
2 |
0.0000 |
| 725 |
SHOCK |
1 |
0.0000 |
| 726 |
SEIZURE |
5 |
0.0000 |
| 727 |
BACK PAIN |
10 |
0.0000 |
| 728 |
RENAL DISORDER |
2 |
0.0000 |
| 729 |
BURNING SENSATION |
3 |
0.0000 |
| 730 |
MOBILITY DECREASED |
3 |
0.0000 |
| 731 |
LOCALISED INFECTION |
1 |
0.0000 |
| 732 |
CEREBROVASCULAR ACCIDENT |
7 |
0.0000 |
| 733 |
CONSTIPATION |
9 |
0.0000 |
| 734 |
UNDERDOSE |
3 |
0.0000 |
| 735 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 736 |
LUNG DISORDER |
2 |
0.0000 |
| 737 |
PAIN IN EXTREMITY |
12 |
0.0000 |
| 738 |
DYSPNOEA |
23 |
0.0000 |
| 739 |
AGEUSIA |
1 |
0.0000 |
| 740 |
WEIGHT DECREASED |
11 |
0.0000 |
| 741 |
DIABETES MELLITUS |
3 |
0.0000 |
| 742 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 743 |
HAEMATOMA |
1 |
0.0000 |
| 744 |
SPEECH DISORDER |
2 |
0.0000 |
| 745 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 746 |
ANHEDONIA |
1 |
0.0000 |
| 747 |
PANCREATITIS |
2 |
0.0000 |
| 748 |
DEPRESSED MOOD |
2 |
0.0000 |
| 749 |
BRADYCARDIA |
2 |
0.0000 |
| 750 |
EAR INFECTION |
1 |
0.0000 |
| 751 |
PLATELET COUNT DECREASED |
4 |
0.0000 |
| 752 |
PRODUCT USE ISSUE |
7 |
0.0000 |
| 753 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 754 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 755 |
GAIT DISTURBANCE |
7 |
0.0000 |
| 756 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 757 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 758 |
HAEMOPTYSIS |
1 |
0.0000 |
| 759 |
URTICARIA |
6 |
0.0000 |
| 760 |
NECK PAIN |
2 |
0.0000 |
| 761 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 762 |
ANXIETY |
10 |
0.0000 |
| 763 |
HERPES ZOSTER |
2 |
0.0000 |
| 764 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 765 |
BALANCE DISORDER |
3 |
0.0000 |
| 766 |
INFECTION |
5 |
0.0000 |
| 767 |
DYSSTASIA |
1 |
0.0000 |
| 768 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 769 |
WHEEZING |
2 |
0.0000 |
| 770 |
ARTHRALGIA |
14 |
0.0000 |
| 771 |
RENAL INJURY |
1 |
0.0000 |
| 772 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 773 |
IRRITABILITY |
2 |
0.0000 |
| 774 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 775 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 776 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 777 |
EPILEPSY |
1 |
0.0000 |
| 778 |
MUSCLE SPASMS |
6 |
0.0000 |
| 779 |
ADVERSE EVENT |
3 |
0.0000 |
| 780 |
DYSPHAGIA |
3 |
0.0000 |
| 781 |
HEAD INJURY |
1 |
0.0000 |
| 782 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 783 |
CYSTITIS |
1 |
0.0000 |
| 784 |
MOOD SWINGS |
1 |
0.0000 |
| 785 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 786 |
DIARRHOEA |
20 |
0.0000 |
| 787 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 788 |
CHOLELITHIASIS |
1 |
0.0000 |
| 789 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 790 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 791 |
VIRAL INFECTION |
1 |
0.0000 |
| 792 |
FUNGAL INFECTION |
1 |
0.0000 |
| 793 |
URINARY RETENTION |
1 |
0.0000 |
| 794 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 795 |
GAIT INABILITY |
1 |
0.0000 |
| 796 |
HYPOTENSION |
6 |
0.0000 |
| 797 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 798 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 799 |
ILLNESS |
3 |
0.0000 |
| 800 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 801 |
RASH MACULAR |
1 |
0.0000 |
| 802 |
HYPERKALAEMIA |
1 |
0.0000 |
| 803 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 804 |
CRYING |
1 |
0.0000 |
| 805 |
AGITATION |
2 |
0.0000 |
| 806 |
DYSURIA |
1 |
0.0000 |
| 807 |
SEPSIS |
3 |
0.0000 |
| 808 |
HYPOAESTHESIA |
4 |
0.0000 |
| 809 |
ASTHENIA |
10 |
0.0000 |
| 810 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 811 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 812 |
ACNE |
2 |
0.0000 |
| 813 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 814 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 815 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 816 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 817 |
CHILLS |
3 |
0.0000 |
| 818 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 819 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 820 |
DISORIENTATION |
1 |
0.0000 |
| 821 |
THROMBOSIS |
2 |
0.0000 |
| 822 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 823 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 824 |
TREATMENT FAILURE |
2 |
0.0000 |
| 825 |
POLLAKIURIA |
1 |
0.0000 |
| 826 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 827 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 828 |
MYALGIA |
4 |
0.0000 |
| 829 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 830 |
MENTAL DISORDER |
1 |
0.0000 |
| 831 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 832 |
INJECTION SITE PAIN |
7 |
0.0000 |
| 833 |
MALAISE |
10 |
0.0000 |
| 834 |
PAIN |
14 |
0.0000 |
| 835 |
RENAL FAILURE |
3 |
0.0000 |
| 836 |
LIVER DISORDER |
1 |
0.0000 |
| 837 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 838 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 839 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 840 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 841 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 842 |
VOMITING |
10 |
0.0000 |
| 843 |
ARRHYTHMIA |
1 |
0.0000 |
| 844 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 845 |
CONTUSION |
2 |
0.0000 |
| 846 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 847 |
SYNCOPE |
2 |
0.0000 |
| 848 |
FLUSHING |
2 |
0.0000 |
| 849 |
HAEMORRHAGE |
2 |
0.0000 |
| 850 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 851 |
DRUG INTERACTION |
3 |
0.0000 |
| 852 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 853 |
PNEUMONIA |
6 |
0.0000 |
| 854 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 855 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 856 |
TREMOR |
3 |
0.0000 |
| 857 |
ARTHROPATHY |
1 |
0.0000 |
| 858 |
MEDICATION ERROR |
1 |
0.0000 |
| 859 |
WEIGHT INCREASED |
4 |
0.0000 |
| 860 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 861 |
BLADDER CANCER |
1 |
0.0000 |
| 862 |
JOINT SWELLING |
2 |
0.0000 |
| 863 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 864 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 865 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 866 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 867 |
ANAEMIA |
3 |
0.0000 |
| 868 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 869 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 870 |
AMNESIA |
1 |
0.0000 |
| 871 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 872 |
PSORIASIS |
2 |
0.0000 |
| 873 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 874 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 875 |
INJURY |
1 |
0.0000 |
| 876 |
OVERDOSE |
3 |
0.0000 |
| 877 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 878 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 879 |
HOSPITALISATION |
2 |
0.0000 |
| 880 |
ARTHRITIS |
1 |
0.0000 |
| 881 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 882 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 883 |
PYREXIA |
4 |
0.0000 |
| 884 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 885 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 886 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 887 |
DEVICE ISSUE |
1 |
0.0000 |
| 888 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 889 |
SWELLING |
1 |
0.0000 |
| 890 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 891 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 892 |
ASTHMA |
1 |
0.0000 |
| 893 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 894 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 895 |
HYPERHIDROSIS |
1 |
0.0000 |
| 896 |
DEHYDRATION |
1 |
0.0000 |
| 897 |
DRY SKIN |
1 |
0.0000 |
| 898 |
DRUG DOSE OMISSION |
1 |
0.0000 |